Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Development of an acute, short-term exposure model for phosgene.

Hobson ST, Casillas RP, Richieri RA, Nishimura RN, Weisbart RH, Tuttle R, Reynolds GT, Parseghian MH.

Toxicol Mech Methods. 2019 Oct;29(8):604-615. doi: 10.1080/15376516.2019.1636170. Epub 2019 Jul 16.

PMID:
31237465
2.

Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury.

Tanimoto T, Parseghian MH, Nakahara T, Kawai H, Narula N, Kim D, Nishimura R, Weisbart RH, Chan G, Richieri RA, Haider N, Chaudhry F, Reynolds GT, Billimek J, Blankenberg FG, Sengupta PP, Petrov AD, Akasaka T, Strauss HW, Narula J.

J Am Coll Cardiol. 2017 Sep 19;70(12):1479-1492. doi: 10.1016/j.jacc.2017.07.762.

3.

Combining intracellular antibodies to restore function of mutated p53 in cancer.

Chan G, Jordaan G, Nishimura RN, Weisbart RH.

Int J Cancer. 2016 Jan 1;138(1):182-6. doi: 10.1002/ijc.29685. Epub 2015 Sep 3.

4.

DNA-dependent targeting of cell nuclei by a lupus autoantibody.

Weisbart RH, Chan G, Jordaan G, Noble PW, Liu Y, Glazer PM, Nishimura RN, Hansen JE.

Sci Rep. 2015 Jul 9;5:12022. doi: 10.1038/srep12022.

5.

Optimizing a lupus autoantibody for targeted cancer therapy.

Noble PW, Chan G, Young MR, Weisbart RH, Hansen JE.

Cancer Res. 2015 Jun 1;75(11):2285-91. doi: 10.1158/0008-5472.CAN-14-2278. Epub 2015 Apr 1.

6.

A nucleolytic lupus autoantibody is toxic to BRCA2-deficient cancer cells.

Noble PW, Young MR, Bernatsky S, Weisbart RH, Hansen JE.

Sci Rep. 2014 Aug 5;4:5958. doi: 10.1038/srep05958.

7.

BRAF splice variants in rheumatoid arthritis synovial fibroblasts activate MAPK through CRAF.

Weisbart RH, Chan G, Li E, Farmani N, Heinze E, Rubell A, Nishimura RN, Colburn K.

Mol Immunol. 2013 Oct;55(3-4):247-52. doi: 10.1016/j.molimm.2013.02.001. Epub 2013 Mar 19.

PMID:
23517740
8.

Targeting cancer with a lupus autoantibody.

Hansen JE, Chan G, Liu Y, Hegan DC, Dalal S, Dray E, Kwon Y, Xu Y, Xu X, Peterson-Roth E, Geiger E, Liu Y, Gera J, Sweasy JB, Sung P, Rockwell S, Nishimura RN, Weisbart RH, Glazer PM.

Sci Transl Med. 2012 Oct 24;4(157):157ra142. doi: 10.1126/scitranslmed.3004385.

9.

A cell-penetrating bispecific antibody for therapeutic regulation of intracellular targets.

Weisbart RH, Gera JF, Chan G, Hansen JE, Li E, Cloninger C, Levine AJ, Nishimura RN.

Mol Cancer Ther. 2012 Oct;11(10):2169-73. doi: 10.1158/1535-7163.MCT-12-0476-T. Epub 2012 Aug 3.

10.

Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways.

Heinze E, Chan G, Mory R, Khavari R, Alavi A, Chung SY, Nishimura RN, Weisbart RH.

Oncol Lett. 2011 Jul;2(4):665-668. Epub 2011 May 13.

11.

BRAF drives synovial fibroblast transformation in rheumatoid arthritis.

Weisbart RH, Chan G, Heinze E, Mory R, Nishimura RN, Colburn K.

J Biol Chem. 2010 Nov 5;285(45):34299-303. doi: 10.1074/jbc.C110.168195. Epub 2010 Sep 14.

12.

Recombinant Fv-Hsp70 protein mediates neuroprotection after focal cerebral ischemia in rats.

Zhan X, Ander BP, Liao IH, Hansen JE, Kim C, Clements D, Weisbart RH, Nishimura RN, Sharp FR.

Stroke. 2010 Mar;41(3):538-43. doi: 10.1161/STROKEAHA.109.572537. Epub 2010 Jan 14.

13.

p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis.

Ma QL, Yang F, Calon F, Ubeda OJ, Hansen JE, Weisbart RH, Beech W, Frautschy SA, Cole GM.

J Biol Chem. 2008 May 16;283(20):14132-43. doi: 10.1074/jbc.M708034200. Epub 2008 Mar 17.

14.

Intranuclear protein transduction through a nucleoside salvage pathway.

Hansen JE, Tse CM, Chan G, Heinze ER, Nishimura RN, Weisbart RH.

J Biol Chem. 2007 Jul 20;282(29):20790-3. Epub 2007 May 24.

15.

Antibody-mediated p53 protein therapy prevents liver metastasis in vivo.

Hansen JE, Fischer LK, Chan G, Chang SS, Baldwin SW, Aragon RJ, Carter JJ, Lilly M, Nishimura RN, Weisbart RH, Reeves ME.

Cancer Res. 2007 Feb 15;67(4):1769-74.

16.

Antibody-mediated Hsp70 protein therapy.

Hansen JE, Sohn W, Kim C, Chang SS, Huang NC, Santos DG, Chan G, Weisbart RH, Nishimura RN.

Brain Res. 2006 May 9;1088(1):187-96. Epub 2006 Apr 21.

PMID:
16630585
17.

Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.

Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE, Weisbart RH, Teter B, Frautschy SA, Cole GM.

Nat Neurosci. 2006 Feb;9(2):234-42. Epub 2006 Jan 15.

PMID:
16415866
18.

Antibody mediated transduction of therapeutic proteins into living cells.

Hansen JE, Weisbart RH, Nishimura RN.

ScientificWorldJournal. 2005 Sep 16;5:782-8. Review.

19.

Selective IgA immune unresponsiveness to Proteus mirabilis fumarate reductase A-chain in rheumatoid arthritis.

Weisbart RH, Min Y, Wong AL, Kang J, Kwunyeun S, Lin A, Kim J, Chan G, Wakelin R, Sohn W, Chang SS, Nishimura RN.

J Rheumatol. 2005 Jul;32(7):1208-12.

PMID:
15996053
20.

An intracellular delivery vehicle for protein transduction of micro-dystrophin.

Weisbart RH, Hansen JE, Nishimura RN, Chan G, Wakelin R, Chang SS, Baresi L, Chamberlain JS.

J Drug Target. 2005 Feb;13(2):81-7.

PMID:
15823959
21.

Antibody-mediated transduction of p53 selectively kills cancer cells.

Weisbart RH, Hansen JE, Chan G, Wakelin R, Chang SS, Heinze E, Miller CW, Koeffler PH, Yang F, Cole GM, Min YS, Nishimura RN.

Int J Oncol. 2004 Dec;25(6):1867-73.

PMID:
15547728
22.

Construction and expression of a bispecific single-chain antibody that penetrates mutant p53 colon cancer cells and binds p53.

Weisbart RH, Wakelin R, Chan G, Miller CW, Koeffler PH.

Int J Oncol. 2004 Oct;25(4):1113-8.

PMID:
15375563
23.

Nuclear delivery of p53 C-terminal peptides into cancer cells using scFv fragments of a monoclonal antibody that penetrates living cells.

Weisbart RH, Miller CW, Chan G, Wakelin R, Ferreri K, Koeffler HP.

Cancer Lett. 2003 Jun 10;195(2):211-9.

PMID:
12767530
24.

Antiguanosine antibodies in murine and human lupus have the internal image of G-binding proteins.

Colburn KK, Wong AL, Weisbart RH, Green LM.

J Rheumatol. 2003 May;30(5):993-7.

PMID:
12734894
25.

Cell type specific targeted intracellular delivery into muscle of a monoclonal antibody that binds myosin IIb.

Weisbart RH, Yang F, Chan G, Wakelin R, Ferreri K, Zack DJ, Harrison B, Leinwand LA, Cole GM.

Mol Immunol. 2003 Mar;39(13):783-9.

PMID:
12617993
26.

Novel protein transfection of primary rat cortical neurons using an antibody that penetrates living cells.

Weisbart RH, Baldwin R, Huh B, Zack DJ, Nishimura R.

J Immunol. 2000 Jun 1;164(11):6020-6.

27.

Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.

Spertini F, Leimgruber A, Morel B, Khazaeli MB, Yamamoto K, Dayer JM, Weisbart RH, Lee ML.

J Rheumatol. 1999 Dec;26(12):2602-8.

PMID:
10606369
28.

An autoantibody is modified for use as a delivery system to target the cell nucleus: therapeutic implications.

Weisbart RH, Stempniak M, Harris S, Zack DJ, Ferreri K.

J Autoimmun. 1998 Oct;11(5):539-46.

PMID:
9802941
29.

Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody.

Zack DJ, Stempniak M, Wong AL, Taylor C, Weisbart RH.

J Immunol. 1996 Sep 1;157(5):2082-8.

PMID:
8757330
30.

Two kappa immunoglobulin light chains are secreted by an anti-DNA hybridoma: implications for isotypic exclusion.

Zack DJ, Wong AL, Stempniak M, Weisbart RH.

Mol Immunol. 1995 Dec;32(17-18):1345-53.

PMID:
8643104
31.
32.

Beneficial effects of oral immunoglobulin in rheumatoid arthritis.

Weisbart RH, Ho G, Park C, Fine HV, Wong AL, Zack DJ.

J Clin Rheumatol. 1995 Apr;1(2):135. No abstract available.

PMID:
19077963
33.

DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus.

Zack DJ, Yamamoto K, Wong AL, Stempniak M, French C, Weisbart RH.

J Immunol. 1995 Feb 15;154(4):1987-94.

PMID:
7836777
34.

Novel structural features of autoantibodies in murine lupus: a possible superantigen binding site?

Zack DJ, Wong AL, Weisbart RH.

Immunol Cell Biol. 1994 Dec;72(6):513-20.

PMID:
7698822
36.

The rheumatoid factor reactivity of a human IgG monoclonal autoantibody is encoded by a variant V kappa II L chain gene.

Weisbart RH, Wong AL, Noritake D, Kacena A, Chan G, Ruland C, Chin E, Chen IS, Rosenblatt JD.

J Immunol. 1991 Oct 15;147(8):2795-801.

PMID:
1918992
37.

Apheresis enhances the selective removal of antinuclear antibodies in systemic lupus erythematosus.

Colburn KK, Gusewitch GA, Statian Pooprasert BS, Weisbart RH.

Clin Rheumatol. 1990 Dec;9(4):475-82.

PMID:
2088644
38.

Rheumatoid factors specific for active rheumatoid arthritis.

Noritake DT, Colburn KK, Chan G, Weisbart RH.

Ann Rheum Dis. 1990 Nov;49(11):910-5.

39.

A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus.

Weisbart RH, Noritake DT, Wong AL, Chan G, Kacena A, Colburn KK.

J Immunol. 1990 Apr 1;144(7):2653-8.

PMID:
2319132
40.

Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines.

Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, Williams RE, Golde DW, DiPersio JF.

Blood. 1990 Feb 15;75(4):851-7.

PMID:
1689190
41.

Responses of neutrophils to myeloid growth factors.

Golde DW, Baldwin GC, Weisbart RH.

Ciba Found Symp. 1990;148:62-71; discussion 71-5. Review.

PMID:
2180650
42.

Physiology of granulocyte and macrophage colony-stimulating factors in host defense.

Weisbart RH, Golde DW.

Hematol Oncol Clin North Am. 1989 Sep;3(3):401-9. Review.

PMID:
2483721
43.

Colony-stimulating factors and host defense.

Weisbart RH, Gasson JC, Golde DW.

Ann Intern Med. 1989 Feb 15;110(4):297-303. Review.

PMID:
2536530
44.

GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism.

Weisbart RH, Kacena A, Schuh A, Golde DW.

Nature. 1988 Apr 14;332(6165):647-8.

PMID:
2451784
45.

Human monoclonal IgG rheumatoid factor has structural homology with bacterial Fc receptor proteins.

Weisbart RH, Noritake DT, Colburn KK, Saxton RE.

J Immunol. 1987 Nov 1;139(9):2925-8.

PMID:
3499461
46.
47.

Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors.

Weisbart RH, Golde DW, Gasson JC.

J Immunol. 1986 Dec 1;137(11):3584-7.

PMID:
3491142
48.

Twins discordant for Wegener's granulomatosis.

Weiner SR, Kwan LW, Paulus HE, Caro XJ, Weisbart RH.

Clin Exp Rheumatol. 1986 Oct-Dec;4(4):389-90. No abstract available.

PMID:
3791724
49.

Wegener's granulomatosis in the elderly.

Weiner SR, Paulus HE, Weisbart RH.

Arthritis Rheum. 1986 Sep;29(9):1157-9.

PMID:
3753542
50.

Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils.

Fleischmann J, Golde DW, Weisbart RH, Gasson JC.

Blood. 1986 Sep;68(3):708-11.

PMID:
3488777

Supplemental Content

Loading ...
Support Center